First human test of experimental Parkinson's drug begins
NCT ID NCT04867642
Summary
This was the first study in humans to test the safety of a new experimental drug called UCB0022 for Parkinson's disease. Researchers gave different doses to 100 healthy volunteers and people with Parkinson's to check for side effects and see how the body processes the drug. The study did not test whether the drug actually helps Parkinson's symptoms - that would come in later trials if this safety check went well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UP0091 1
London, United Kingdom
Conditions
Explore the condition pages connected to this study.